More than 2,000 professionals in psychiatry and mental health met in oviedo next week at its annual Congress

the 15th National Congress of Psychiatry begins the next Tuesday, 7 de November.

– the Spanish societies of Biological Psychiatry and Psychiatry against stigma Oviedo Declaration will be presented during the Congress patients with a diagnosis of severe mental illness.

– According to experts, the new regulation by active ingredient could harm adherence to the treatment of persons with a diagnosis of mental illness ”.

– the main themes of the Congress among the novelties of the international classification of diseases (ICD-11), the State of neuropsychiatric diseases in Europe and advances in early diagnosis of these diseases.

– additionwill cover the developments in the field of genetics applied to mental health, addictions and mental illness, gender violence and mental health, impact on mental health child abuse, suicide, disorders of eating and sleeping, etc.

– also will highlight the latest advances in the pharmacological therapy with the emergence of new drugs this year.

Oviedo, 2011-October Over two thousand professionals in psychiatry and mental health will gather at the Palacio de Exposiciones y Congresos, Oviedo next week – from 8 to 11 November — on the occasion of the 15th National Congress of Psychiatry, to be held under the motto ‘ for excellence and professional development ’. Organized by the Spanish society of Biological Psychiatry (SEPB) and the Spanish society of Psychiatry (SEP), is the most important event of this area in all Latin America.

As Dr. Julio Bobes, President of the Organizing Committee, has developed during the Congress will get highlighted all the advances in the field of Psychiatry and mental health, have occurred in the past year, both in the research section and in the diagnosis and treatment ”. In addition, during the Congress will be presented the Declaration of Oviedo in the Spanish societies of Biological Psychiatry and Psychiatry against the stigma of patients with a diagnosis of severe mental illness ”.

Mental illness and prescription by active ingredient

Dr. Bobes, who is also Professor at the University of Oviedo, has affected in that this will be the first Congress which will be existing regulations on prescription by active ingredient, approved by decree-law, and it’s a regulation whose limits are insufficiently clear, which can lead to certain problems ”.

Among these, the head of the tenth fifth National Congress of psychiatry has cited that the new regulation affects our requirements and can cause problems with adherence to the treatment of persons with serious mental illness. This type of people with this diagnosis presented major problems because of their pathology to maintain their adherence to treatment; to prescribe by active ingredient, the name and presentation of the medicinal product may change several times, but the active principle is the same; This can lead to confusion for the patient and, therefore, to stop the treatment, the serious consequences that this neglect can be harnessed together ”.

The expert continued explaining the possible impact of the limitation period for active ingredient and its influence on the health of persons with a diagnosis of mental illness, by clarifying that are talking about a few patients with a low awareness of disease and, moreover, of not being properly controlled with treatment, can jeopardize seriously their health ”.

Main topics of the Congress

The main topics to be addressed in the Congress, in addition to aforementioned combating stigma and the presentation of the Declaration of Oviedo, among the developments of the international classification of diseases (ICD-11), the State of neuropsychiatric diseases in Europe and advances in early diagnosis of these diseases, advances in the field of genetics applied to mental health, addictions and mental illness, gender-based violence and mental health, impact on mental health child abuses and lack of adequate family care, suicide, disorders of eating and sleeping, etc.

Also they will highlight the latest advances in the pharmacological therapy with the emergence of new drugs on the market aimed at patients with a diagnosis of bipolar illness, depression, and psychosis; the uneven application of the law of unit in the different autonomous communities

the appointment will come American professionals, which will highlight the Argentine doctor Alfredo Cía, President of the Psychiatric Association of Latin America and the Caribbean (APAL). In addition to the two organizing scientific societies (SEP and SEPB), in the Scientific Committee of the Congress are participating representatives of various international psychiatric organizations (World Association of Psychiatry and APAL), national (Spanish Foundation of Mental Health and Psychiatry and the center of biomedical research in Mental health network) and regional)(such as the society Basque-Navarre of Psychiatry).